Immune checkpoint inhibitors in pediatric hematologic malignancies
The use of immune checkpoint inhibitors as therapy in adult patients with malignancy has resulted in an improvement in overall survival. Research on the use of these drugs in pediatric oncology is just beginning. However, the results already obtained indicate the possibility of successful use of che...
Saved in:
| Main Author: | I. V. Gribkova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2023-05-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/814 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune-checkpoint inhibitors for glioblastoma: what have we learned?
by: Antonio Omuro
Published: (2022-08-01) -
The burden and clinical trajectory of immune checkpoint inhibitor-induced endocrinopathies: an 8-year experience
by: Fateen Ata, et al.
Published: (2024-12-01) -
Case Report: Acral vasculitis induced by Immune Checkpoint Inhibitors: a case series and literature review
by: Valérian Rivet, et al.
Published: (2025-05-01) -
Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
by: K. V. Menshikov, et al.
Published: (2022-10-01) -
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience
by: Tony Z. Zhuang, et al.
Published: (2025-01-01)